Maker of Narcan Nasal Spray Plans to Sell Overdose Antidote for Less Than $50
FRIDAY, April 21, 2023 (HealthDay News) — The company that makes the opioid overdose nasal spray Narcan plans to have it available in pharmacies and online by late summer for a price of less than $50.Emergent sent a response letter Thursday to Sen. R…
Learn MoreMaker of Narcan Nasal Spray Plans to Sell Overdose Antidote for Less Than $50
FRIDAY, April 21, 2023 (HealthDay News) — The company that makes the opioid overdose nasal spray Narcan plans to have it available in pharmacies and online by late summer for a price of less than $50. Emergent sent a response letter Thursday to Sen. …
Learn MoreProveer medicamentos para la adicción a los reclusos puede reducir las muertes por sobredosis
MARTES, 18 de abril de 2023 (HealthDay News) — Ofrecer medicamentos para el trastorno por el uso de opioides a los reclusos podría significar menos muertes por sobredosis más adelante, sugiere una investigación reciente. “Ofrecer medicamentos para la…
Learn MoreFibromyalgia Is Risk Factor for Opioid Use Disorder Exacerbations
WEDNESDAY, April 19, 2023 (HealthDay News) — Fibromyalgia is a risk factor for pain-related exacerbation of opioid use disorder (OUD), according to a study published online March 14 in PAIN.Orman Trent Hall, D.O., from the Ohio State University Wexne…
Learn MorePlacebo + Methadone Improves Opioid Use Disorder Treatment Retention
TUESDAY, April 18, 2023 (HealthDay News) — A conditioned open-label placebo (C-OLP) may be a beneficial, low-risk adjunct to methadone treatment of opioid use disorder, according to a study published online April 12 in JAMA Network Open.Annabelle M. …
Learn MoreLa mezcla de un tranquilizante veterinario y fentanilo es una ‘amenaza emergente’, advierten las autoridades
MIÉRCOLES, 12 de abril de 2023 (HealthDay News) — Las autoridades de EE. UU. intensifican los esfuerzos por acabar con el uso ilícito de un tranquilizante de uso veterinario, la xilacina, que puede provocar unos efectos secundarios dolorosos y letale…
Learn MoreBuprenorphine Cuts Risk for Death After Nonfatal, Opioid-Involved Overdose
THURSDAY, April 13, 2023 (HealthDay News) — Buprenorphine treatment after nonfatal opioid-involved overdose is associated with significant decline in the risk for opioid-involved overdose death, according to a study published online March 10 in the A…
Learn MoreFrenar las recetas de opioides no aumentará las tasas de suicidio, según un estudio
MARTES, 11 de abril de 2023 (HealthDay News) — En los últimos años, la intensificación de la crisis de opioides ha provocado un complejo debate sobre la mejor forma de controlar el riesgo de suicido entre los pacientes a quienes se recetan estos anal…
Learn MoreMix of Vet Tranquilizer, Fentanyl an ‘Emerging Threat,’ U.S. Officials Warn
WEDNESDAY, April 12, 2023 (HealthDay News) — U.S. officials are intensifying efforts to crack down on illicit use of the veterinary tranquilizer xylazine, which can cause painful and deadly side effects in humans.The drug, when mixed with the opioid …
Learn MoreRehab Care for Opioid Addiction Often Tough to Find: Study
WEDNESDAY, April 12, 2023 (HealthDay News) — The United States is in the middle of an opioid crisis, yet new research shows that only about 7% of Americans on Medicaid who have opioid use disorder receive residential treatment. This means that many p…
Learn More